Neurological and psychiatric problems occur in 15–40% of late-stage Lyme patients. Depression and anxiety appear in approximately 40% of people with disseminated Lyme disease — either before or after initial antibiotic treatment. In some patients, psychiatric or cognitive symptoms are the only symptoms. A large Danish cohort study published in the American Journal of Psychiatry found associations between Lyme borreliosis and depression, suicidal ideation, OCD, and psychosis. These are not small signals in small studies.
Neuropsychiatric symptoms in Lyme disease are not rare — they are underrecognised. When a patient presenting with anxiety, depression, rage, or OCD-like symptoms has a history of tick exposure, lives in an endemic area, or has other physical symptoms consistent with tick-borne illness, Lyme disease must be on the differential — not dismissed because the symptoms "look psychiatric."
How Borrelia reaches the brain
Borrelia burgdorferi is not simply a joint-dwelling bacterium that occasionally causes neurological complications. It is a neurotropic spirochete — one that actively penetrates the central nervous system. Research has confirmed that Borrelia can be isolated from cerebrospinal fluid as early as 18 days after the tick bite. In primate models, the spirochete has been detected in the leptomeninges, dorsal root ganglia, and brain parenchyma. The bacterium crosses the blood-brain barrier using host enzymes called proteases to tunnel through the endothelial cells lining brain blood vessels.
Once inside the CNS — what happens
Once in the CNS, Borrelia triggers microglial activation and inflammatory cytokine release. This neuroinflammation disrupts serotonin, dopamine, and glutamate signalling — the same neurotransmitter systems targeted by psychiatric medications. The result is indistinguishable from primary psychiatric illness on the surface: mood changes, anxiety, altered behaviour, cognitive dysfunction. But the root cause is infectious, not primary psychiatric. And antibiotics — not psychotropic drugs — are the appropriate first response.
Critically, these neuropsychiatric symptoms can appear at any stage of Lyme disease. They can emerge weeks after the tick bite during early dissemination, or months and years later in chronic late-stage disease. They fluctuate — waxing and waning rather than following the steady progressive course typical of primary psychiatric disorders. This fluctuation is an important clinical clue: primary OCD or primary depression does not oscillate in the same way as infection-driven psychiatric symptoms.
The full spectrum — mood, behaviour, cognition, and beyond
- Depression — often treatment-resistant to SSRIs alone
- Anxiety — frequently severe and disproportionate
- Panic attacks — sudden onset, no obvious trigger
- Rapid mood swings mimicking bipolarity
- Emotional lability — crying for no clear reason
- Depersonalisation and derealisation
- Suicidal ideation — documented in Danish cohort study
- Rage attacks — sudden, intense, disproportionate
- Irritability far beyond normal baseline
- Impulsivity and poor impulse control
- OCD-like thoughts and compulsive behaviours
- Obsessive or intrusive thinking
- Social withdrawal and isolation
- Aggression (rare but documented)
- Memory impairment — short-term most affected
- Brain fog — thinking through cotton wool
- Word-finding difficulties
- Slowed information processing
- Difficulty concentrating or sustaining attention
- Dyslexia-like reading problems
- Visual-spatial disorientation, getting lost easily
- Psychosis — hallucinations, delusions
- Paranoia
- Mania
- Seizures
- Confusion and disorientation
- Sleep disorders — insomnia, hypersomnia, vivid nightmares
- Sensitivity to light, sound, and smells
In some patients — particularly in late-stage or chronic Lyme — psychiatric and cognitive symptoms may be the only presenting complaints. There may be no joint pain, no rash history, no classic physical Lyme symptoms at all. This subset of patients is particularly vulnerable to being labelled with primary psychiatric diagnoses, receiving psychotropic medications that address the symptom but not the cause, and never being tested for tick-borne illness. One study found evidence of Borrelia infection in one third of psychiatric inpatients in an endemic area.
What Lyme looks like — and what it gets called instead
The psychiatric presentation of Lyme disease is described by neuropsychiatrist Dr. Robert C. Bransfield — one of the leading researchers in this area — as the "great imitator" of mental illness. The symptoms are real. The diagnoses patients receive are not fabricated. But they are wrong — or at least incomplete — because the underlying infectious driver is missed.
Many Lyme patients describe a pivotal moment in their medical journey: an infectious disease specialist, GP, or neurologist reviews their tests — which are negative or equivocal — and says "there's nothing wrong physically, you should see a psychiatrist." This is sometimes presented as compassionate. It is experienced as dismissal. And in cases where the underlying driver is infectious, it delays the correct treatment by months or years while the patient accumulates more diagnoses, more medications, and more suffering. This does not mean psychiatric support has no value — integrated care is often appropriate. But it must not substitute for investigating whether a physical cause exists.
Neuropsychiatric Lyme in children and adolescents
Children are not simply small adults when it comes to neuropsychiatric Lyme. A 2004 Columbia University study found that children with Lyme disease showed substantial cognitive and psychiatric disturbances — and critically, these cognitive impairments persisted even after controlling for anxiety, depression, and fatigue. The brain effects are direct, not secondary.
Memory impairment, slowed processing, difficulty concentrating, and word-finding problems directly affect school performance. Children who were previously high achievers may suddenly struggle. Teachers may interpret this as laziness, attitude, or ADHD. Parents may be told their child is "just stressed."
Rage, irritability, regression (bedwetting in older children), social withdrawal, sudden onset of OCD-like behaviours — these are all documented manifestations of neuropsychiatric Lyme in children. Family members are often the first to notice dramatic personality changes that the child themselves may not be aware of.
Paediatric Acute-Onset Neuropsychiatric Syndrome (PANS) — characterised by sudden onset of OCD, anxiety, or regression — has been linked to both Bartonella and Borrelia infection. In one study, 74% of children with a PANDAS/PANS-like presentation who were tested had positive blood tests for tick-borne disorders. Sudden, dramatic psychiatric change in a child after suspected tick exposure deserves serious investigation.
Teenagers with Lyme-driven neuropsychiatric symptoms are at particular risk of misdiagnosis because mood instability, social withdrawal, and declining academic performance are attributed to normal adolescence. A 16-year-old presenting with depression may wait years for a correct diagnosis when the actual cause is an untreated tick-borne infection.
Signs that psychiatric symptoms may have an infectious cause
No single feature definitively distinguishes Lyme-driven psychiatric symptoms from primary psychiatric illness — but several clinical patterns increase the probability that a physical cause deserves investigation.
| Feature | Suggests infectious origin |
|---|---|
| Onset pattern | Sudden or sub-acute onset without clear life stressor; may coincide with a febrile illness or identified tick bite |
| Symptom fluctuation | Waxing and waning rather than steady progression; periods of notable improvement alternating with crashes |
| Treatment response | Failure to respond to appropriate psychiatric medications at therapeutic doses; improvement only with antibiotics |
| Physical co-symptoms | Fatigue, joint pain, night sweats, or other physical symptoms accompanying the psychiatric picture |
| No psychiatric history | New-onset psychiatric symptoms in a person with no prior mental health history, especially in middle age |
| Geographic and lifestyle context | Lives in or has spent time in tick-endemic areas; outdoor activities; pet ownership with tick exposure |
| Cognitive component | Objective memory and processing deficits alongside mood symptoms — rare in primary anxiety or depression |
Treating the cause — and supporting the mind
The most consistent finding across experienced LLMD practitioners and documented case reports is this: when the underlying infection is adequately treated, psychiatric symptoms often improve substantially — sometimes dramatically — without psychiatric medications. This does not mean psychiatric support has no role. It means that treating the infectious driver must be the primary strategy.
Neuropsychiatric symptoms that are driven by active Borrelia infection, Bartonella co-infection, or other tick-borne pathogens can improve significantly with appropriate antibiotic treatment. Doxycycline crosses the blood-brain barrier at therapeutic concentrations. Some LLMD practitioners prefer IV ceftriaxone or other CNS-penetrant antibiotics for pronounced neurological involvement. The treatment duration is typically longer for neurological Lyme than for early or primarily musculoskeletal disease.
Neuropsychiatric symptoms in Lyme patients are often driven substantially by Bartonella co-infection rather than Borrelia alone. Research suggests that Lyme-Bartonella co-infection produces psychiatric syndromes more consistently than Lyme alone. If neuropsychiatric symptoms dominate the clinical picture and are not improving with Lyme-targeted antibiotics, specifically addressing Bartonella with rifampin-based protocols may produce significant improvement.
Treating the infection and providing psychiatric support are not mutually exclusive. Many patients benefit from both simultaneously. The key principle is that psychiatric treatment should not replace investigation of an underlying physical cause. And psychiatric labels should not be applied so quickly that the infectious differential is never explored. A patient can legitimately have anxiety — and also have Lyme disease causing that anxiety. Both deserve attention.
When antibiotic treatment for Lyme or Bartonella begins, psychiatric symptoms can temporarily worsen before they improve. This Herxheimer reaction in the CNS — driven by inflammatory responses to dying bacteria — can manifest as increased anxiety, rage, or cognitive fog. Understanding this pattern helps patients and practitioners not abandon effective treatment prematurely during a difficult initial phase.
One of the most painful experiences in the Lyme journey is being told that what you're feeling is in your head. It isn't. The brain is an organ — it can become infected, inflamed, and functionally disrupted by bacteria, just like the heart or the joints. The distinction between "physical" and "mental" illness was never scientifically clean, and in tick-borne disease it collapses entirely. Your symptoms are real. The suffering is real. And finding a practitioner who understands this changes everything.
Sources & further reading
- Bransfield RC — Neuropsychiatric Lyme Borreliosis: An Overview with a Focus on a Specialty Psychiatrist's Clinical Practice. Healthcare, 2018
- Fallon BA, Nields JA — Lyme disease: a neuropsychiatric illness. American Journal of Psychiatry, 1994
- Benros ME et al. — Lyme Borreliosis and Associations With Mental Disorders and Suicidal Behavior. American Journal of Psychiatry, 2022
- Cameron D — Neuropsychiatric Lyme Disease: Infection, Not Mental Illness. danielcameronmd.com, 2020
- Columbia University Lyme Research Center — Cognitive and psychiatric disturbances in children with Lyme disease, 2004
- PMC546937 — Borrelia burgdorferi, Host-Derived Proteases, and the Blood-Brain Barrier
- PMC12239190 — Neuropsychiatric Manifestations of Lyme Disease: A Literature Review
- Greenberg MD R — PANS, PANDAS, and tick-borne disorders in paediatric bipolarity. rosaliegreenbergmd.com
- Project Lyme — Managing Your Mental Health. projectlyme.org
Last updated: April 2026